MCRB
Seres Therapeutics, Inc. · Healthcare
Director and 10% owner Noubar Afeyan bought $20.0M of Seres Therapeutics, Inc.
Bought$19,999,998
$2.25Price
8,888,888Shares
+108%Stake
What MCRB did for a copier
Prices for MCRB after this filing aren't in yet.
Noubar Afeyan's record
1 other buy on record. A record shows here once 3 of them have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, Jun 18. Filed Thu, Jun 20, 4:17 PM ET, after the close. Not investment advice.